Discover 2,010 paid clinical trials in Michigan. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Michigan offers access to numerous clinical research opportunities for both healthy volunteers interested in paid studies and those with specific health conditions. Research hubs in Detroit, Grand Rapids, and Ann Arbor are enrolling participants, providing access to innovative treatments and personalized care options.
Filter
1
Filter results
Results: 2,010
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
for
Gastric Cancer
Location: New York NY, Grand Rapids MI, Baton Rouge LA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT05702229
Phase2, Recruiting
Quantitative MRI Assessment of Breast Cancer Therapy Response
for
Breast Cancer
Location: Royal Oak MI, Iowa City IA, Seattle WA
Sponsor: Corewell Health East
Sex: All
Age: 18+
Code: NCT05704062
Recruiting
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
for
Pain, Sickle Cell Disease
Location: Hartford CT, New York NY, Newark NJ, Greenville NC,
Sponsor: University of Pittsburgh
Sex: All
Age: 16 - 30
Code: NCT06374238
Recruiting
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
for
Advanced Melanoma
Location: Providence RI, Lebanon NH, Lake Success NY,
Sponsor: Replimune, Inc.
Sex: All
Age: 12+
Code: NCT06264180
Phase3, Recruiting
A Study of BLB-201 RSV Vaccine in Infants and Children
for
Respiratory Syncytial Virus Infections
Location: Beachwood OH, Greenville SC, Allen Park MI,
Sponsor: Blue Lake Biotechnology Inc.
Sex: All
Age: 0 - 5
Code: NCT05655182
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
for
Amblyopia
Location: Boston MA, New York NY, Philadelphia PA, Norfolk VA,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 8 - 12
Code: NCT06524882
Phase3, Recruiting
Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy
for
Radiation Retinopathy, Visual Impairment
Location: Boston MA, Manchester CT, Philadelphia PA,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 18+
Code: NCT05844982
Phase3, Recruiting
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
for
Advanced Colorectal Carcinoma,
Location: Lake Success NY, New York NY, Millville DE,
Sponsor: University of Rochester
Sex: All
Age: 18+
Code: NCT06073431
Recruiting
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
for
Carcinoma, Non-Small-Cell Lung
Location: Boston MA, Shirley NY, New Haven CT, Lebanon NH,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06667076
Phase2, Recruiting
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
for
Hemophilia A With Inhibitor, Hemophilia B With Inhibitor
Location: Boston MA, New Hyde Park NY, Savannah GA, Cleveland OH,
Sponsor: American Thrombosis and Hemostasis Network
Sex: All
Age: 12 - 70+
Code: NCT04647227
Recruiting
VENOUS: A Translational Study of Enterococcal Bacteremia
for
Enterococcal Bacteremia
Location: Chapel Hill NC, Miami FL, Pittsburgh PA, Detroit MI,
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 18+
Code: NCT04410276
Recruiting
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
for
Dravet Syndrome
Location: Durham NC, Miami FL, Ann Arbor MI, Chicago IL,
Sponsor: Encoded Therapeutics
Sex: All
Age: 0 - 17
Code: NCT05419492
Phase1, Phase2, Recruiting
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
for
Monoclonal Gammopathy of Undetermined Significance (MGUS),
Location: Weymouth MA, Boston MA, Brighton MA, Methuen MA,
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT02269592
Recruiting
Clarifying the Optimal Application of SLT Therapy Trial
for
Glaucoma and Ocular Hypertension
Location: Boston MA, Reading MA, The Bronx NY, Philadelphia PA,
Sponsor: University of Pittsburgh
Sex: All
Age: 18+
Code: NCT04967989
Phase3, Recruiting
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
for
Generalized Myasthenia Gravis
Location: Foxborough MA, The Bronx NY, New York NY,
Sponsor: Vor Biopharma
Sex: All
Age: 18+
Code: NCT06456580
Phase3, Recruiting
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
for
Solid Tumors, Neoplasms
Location: Boston MA, Mineola NY, New York NY, Toronto, Montreal,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06431594
Phase1, Recruiting
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
for
Peanut Allergies
Location: Boston MA, Tampa FL, Ann Arbor MI, Aurora CO,
Sponsor: Mabylon AG
Sex: All
Age: 12 - 55
Code: NCT07287033
Phase1, Recruiting
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
for
Chronic Inducible Urticaria, Cold Urticaria,
Location: New York NY, Baltimore MD, Hialeah FL, Miami Lakes FL,
Sponsor: Celldex Therapeutics
Sex: All
Age: 18+
Code: NCT07266402
Phase3, Recruiting
Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
for
Intracranial Meningioma
Location: Boston MA, New Haven CT, New York NY, Durham NC,
Sponsor: RTOG Foundation, Inc.
Sex: All
Age: 18+
Code: NCT06955169
Phase2, Recruiting
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
for
Angioimmunoblastic T-cell Lymphoma,
Location: Boston MA, Saint Johnsbury VT, Lebanon NH, Commack NY,